- Home
- ARWR vs NEO Comparison
ARWR vs NEO Comparison
Compare ARWR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- NEO
- Stock Information
- Founded
- ARWR 2003
- NEO 2001
- Country
- ARWR United States
- NEO United States
- Employees
- ARWR N/A
- NEO N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- NEO Precision Instruments
- Sector
- ARWR Health Care
- NEO Health Care
- Exchange
- ARWR Nasdaq
- NEO Nasdaq
- Market Cap
- ARWR 2.5B
- NEO 2.1B
- IPO Year
- ARWR 1993
- NEO 1999
- Fundamental
- Price
- ARWR $18.57
- NEO $15.04
- Analyst Decision
- ARWR Buy
- NEO Strong Buy
- Analyst Count
- ARWR 11
- NEO 9
- Target Price
- ARWR $45.33
- NEO $19.89
- AVG Volume (30 Days)
- ARWR 997.3K
- NEO 792.3K
- Earning Date
- ARWR 11-26-2024
- NEO 11-05-2024
- Dividend Yield
- ARWR N/A
- NEO N/A
- EPS Growth
- ARWR N/A
- NEO N/A
- EPS
- ARWR N/A
- NEO N/A
- Revenue
- ARWR $19,648,000.00
- NEO $644,118,000.00
- Revenue This Year
- ARWR N/A
- NEO $12.93
- Revenue Next Year
- ARWR $100.95
- NEO $9.70
- P/E Ratio
- ARWR N/A
- NEO N/A
- Revenue Growth
- ARWR N/A
- NEO 12.06
- 52 Week Low
- ARWR $17.05
- NEO $12.77
- 52 Week High
- ARWR $39.83
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- ARWR 35.87
- NEO 52.58
- Support Level
- ARWR $21.20
- NEO $13.35
- Resistance Level
- ARWR $22.03
- NEO $16.60
- Average True Range (ATR)
- ARWR 0.87
- NEO 0.67
- MACD
- ARWR -0.04
- NEO 0.18
- Stochastic Oscillator
- ARWR 0.76
- NEO 53.98
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.